![]() |
||||
|
||||
|
|
||||
Re: HRT For Women With Breast Cancer - Study HaltedFrom: Ana (aocana58@yahoo.com)Fri Feb 6 15:39:03 2004
Does anybody know what kind of progestin was? I didn't find the specific HRT. Medroxiprogesterone again? Ana Ocana MD "art fougner, md" <evsono@pipeline.com> wrote: only women who had not undergone hysterectomy were on E+P - s/p hysterectomy women were on estrogen alone. "Further analyses were done by subgroups defined by receptor status, tamoxifen treatment, and HRT taken before diagnosis, to elucidate whether the risk seemed isolated to any one subset or if any of these factors strongly modified the effect (table 2). In all subsets, RH was above unity, but the CIs were wide due to the small number of events. An analysis adjusting for the stratification variables and hormone receptor status gave the same overall result as the basic safety analysis (table 2). We compared the risk by specific type of HRT and compared continuously combined, sequential, and other preparations to oestrogens only; the differences were both nominally small and far from statistically significant ..." HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped L Holmberg, H Anderson, for the HABITS steering and data monitoring committees Lancet 2004; 363: 453-55. Published online Feb 3, 2004 art
At Tue, 3 Feb 2004, Braun, R. Daniel wrote:
>
-- art fougner, md ich bin ein New Yorker
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Thu Oct 2 04:45:37 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.